Papers - HATAKEYAMA SHINGO
-
【日本発の臨床研究からみた前立腺癌診療】前立腺癌の診断、悪性度評価に関する日本発のPSA糖鎖変異バイオマーカー
米山 徹, 金子 智典, 彼谷 高敏, 米山 美穂子, 飛澤 悠葵, 畠山 真吾, 大山 力
Prostate Journal 8 ( 2 ) 194 - 203 2021.10
-
転移性去勢感受性前立腺癌に対するUpfront治療の成績 多施設共同研究
田中 壽和, 畠山 真吾, 野呂 大輔, 小玉 寛健, 小西 栄, 沖田 和貴, 細越 正吾, 成田 拓磨, 得居 範子, 岡本 哲平, 山本 勇人, 米山 高広, 橋本 安弘, 齋藤 久夫, 大山 力
日本癌治療学会学術集会抄録集 59回 O62 - 6 2021.10
-
Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era.
Numakura K, Muto Y, Naito S, Hatakeyama S, Kato R, Koguchi T, Kojima T, Kawasaki Y, Kandori S, Kawamura S, Arai Y, Ito A, Nishiyama H, Kojima Y, Obara W, Ohyama C, Tsuchiya N, Habuchi T
Cancer medicine 10 ( 17 ) 5839 - 5846 2021.9
-
Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy.
Matsuda Y, Narita S, Okubo T, Mitsuzuka K, Hatakeyama S, Koizumi A, Koie T, Kawamura S, Tochigi T, Ito A, Oyama C, Arai Y, Habuchi T
Annals of surgical oncology 28 ( 9 ) 5341 - 5348 2021.9
-
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study.
Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 28 ( 9 ) 899 - 905 2021.9
-
Association between female urinary urgency and aponeurotic ptosis: Results from a community-based cross-sectional study in Japan.
Ozaki Y, Okamoto T, Miura Y, Iida K, Uemura N, Sugimura Y, Hatakeyama S, Urushidate S, Ohyama C
Neurourology and urodynamics 40 ( 6 ) 1678 - 1685 2021.8
-
Editorial Comment from Dr Hatakeyama and Dr Ohyama to Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan.
Hatakeyama S, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 28 ( 8 ) 820 2021.8
-
尿路結石形成に関与する糖鎖変異オステオポンチンの検索
阿南 剛, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力
日本内分泌学会雑誌 97 ( S.Update ) 47 - 49 2021.7
-
Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist.
Liu K, Ma Y, Yang Y, Lu J, Zhao J, Du S, Zhang X, Liu C, Del Giudice F, Shiota M, Hatakeyama S, Zhang X, Kang J
Annals of translational medicine 9 ( 14 ) 1173 2021.7
-
前立腺癌患者におけるフレイルとQOLの関係(FRAQ-PC study)
濱谷 智子, 畠山 真吾, 大山 力, 橋本 安弘, 米山 高弘, 今井 篤, 山本 勇人, 米山 徹, 岡本 哲平, 藤田 尚紀, 濱野 逸人, 小島 由太, 岩村 大径, 成田 拓磨, 百田 匡毅
泌尿器外科 34 ( 臨増 ) 799 - 799 2021.6
-
腎臓結石形成に関与する糖鎖変異オステオポンチンの同定
阿南 剛, 米山 徹, 畠山 真吾, 米山 高弘, 橋本 安弘, 佐藤 信, 大山 力
日本腎臓学会誌 63 ( 4 ) 447 - 447 2021.6
-
前立腺癌患者の治療選択とG8スコアの関連性についての検討
富樫 赳, 畠山 真吾, 百田 匡毅, 相馬 理, 田中 壽和, 濱野 逸人, 藤田 尚紀, 岡本 哲平, 米山 徹, 山本 勇人, 今井 篤, 米山 高弘, 橋本 安弘, 大山 力
泌尿器外科 34 ( 臨増 ) 799 - 799 2021.6
-
Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.
Okamoto T, Noro D, Hatakeyama S, Narita S, Mitsuzuka K, Sakurai T, Kawamura S, Hoshi S, Shimoda J, Tanaka T, Kawaguchi T, Ishidoya S, Ito A, Tsuchiya N, Habuchi T, Ohyama C
BMC cancer 21 ( 1 ) 605 2021.5
-
ヌーナン症候群患者に施行した献腎移植の一例
小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力
日本透析医学会雑誌 54 ( Suppl.1 ) 463 - 463 2021.5
-
Narrative review of urinary glycan biomarkers in prostate cancer.
Hatakeyama S, Yoneyama T, Tobisawa Y, Yamamoto H, Ohyama C.
Transl Androl Urol. 2021.4
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama
Urologic oncology 39 ( 4 ) 238.e9 - 238.e17 2021.4
-
Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan.
Yumina Muto, Shintaro Narita, Shingo Hatakeyama, Shinya Maita, Shuji Chiba, Kyohei Kubo, Yuu Aoyama, Ryuichi Ito, Yoshiko Takahashi, Shuhei Takahashi, Kumiko Nakamura, Naoko Honma, Hiromi Sato, Atsushi Koizumi, Ryoma Igarashi, Katsumi Okane, Toshiya Ishida, Yohei Horikawa, Teruaki Kumazawa, Susumu Akihama, Jiro Shimoda, Takehiro Suzuki, Chikara Ohyama, Tomonori Habuchi
Medical oncology (Northwood, London, England) 38 ( 4 ) 37 - 37 2021.3
-
Prognostic significance of total plasma cell-free DNA level and androgen receptor amplification in castration-resistant prostate cancer.
Yuka Kubota, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Itsuto Hamano, Sakae Konishi, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
World journal of urology 2021.3
-
Editorial Comment to Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.
Shingo Hatakeyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2021.3
-
Altered gut microbiome associated with overactive bladder and daily urinary urgency.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
World journal of urology 39 ( 3 ) 847 - 853 2021.3